RPK-739

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameRPK-739
Drug Alias Namecancer vaccine (Replikun)KUN-CSFKUN-GMCSFRPK-739
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy
Mechanisms of ActionMacrophage colony stimulating factor 2 Gene transference
TargetsMacrophage colony stimulating factor 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesReplikun Biotech Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesReplikun Biotech Pty Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A